These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
372 related articles for article (PubMed ID: 30597727)
1. MiR-552 promotes the proliferation, migration and EMT of hepatocellular carcinoma cells by inhibiting AJAP1 expression. Qu W; Wen X; Su K; Gou W J Cell Mol Med; 2019 Feb; 23(2):1541-1552. PubMed ID: 30597727 [TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNA SBF2-AS1 promotes hepatocellular carcinoma progression through regulation of miR-140-5p-TGFBR1 pathway. Li Y; Liu G; Li X; Dong H; Xiao W; Lu S Biochem Biophys Res Commun; 2018 Sep; 503(4):2826-2832. PubMed ID: 30115383 [TBL] [Abstract][Full Text] [Related]
3. miR-876 Inhibits EMT and Liver Fibrosis via POSTN to Suppress Metastasis in Hepatocellular Carcinoma. Chen K; Li Z; Zhang M; Wang B; Peng T; Shen Y; Zhang J; Ye J; Liu Y; Tang D; Peng M; Ma D; Xiao Z; Zhang Y; Jin W; Li X Biomed Res Int; 2020; 2020():1964219. PubMed ID: 33083453 [TBL] [Abstract][Full Text] [Related]
4. Silencing of hsa_circ_0101145 reverses the epithelial-mesenchymal transition in hepatocellular carcinoma via regulation of the miR-548c-3p/LAMC2 axis. Jin J; Liu H; Jin M; Li W; Xu H; Wei F Aging (Albany NY); 2020 Jun; 12(12):11623-11635. PubMed ID: 32554866 [TBL] [Abstract][Full Text] [Related]
5. MicroRNA-370 Regulates Cellepithelial-Mesenchymal Transition, Migration, Invasion, and Prognosis of Hepatocellular Carcinoma by Targeting GUCD1. He Y; He X Yonsei Med J; 2019 Mar; 60(3):267-276. PubMed ID: 30799589 [TBL] [Abstract][Full Text] [Related]
6. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway. Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154 [TBL] [Abstract][Full Text] [Related]
7. MicroRNA-183-5p contributes to malignant progression through targeting PDCD4 in human hepatocellular carcinoma. Duan X; Li W; Hu P; Jiang B; Yang J; Zhou L; Mao X; Tian B Biosci Rep; 2020 Oct; 40(10):. PubMed ID: 33078826 [TBL] [Abstract][Full Text] [Related]
8. CADM2, as a new target of miR-10b, promotes tumor metastasis through FAK/AKT pathway in hepatocellular carcinoma. Li D; Zhang Y; Zhang H; Zhan C; Li X; Ba T; Qiu Z; E F; Lv G; Zou C; Wang C; Si L; Zou C; Li Q; Gao X J Exp Clin Cancer Res; 2018 Mar; 37(1):46. PubMed ID: 29506532 [TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA CRNDE promotes the proliferation, migration and invasion of hepatocellular carcinoma cells through miR-217/MAPK1 axis. Wang H; Ke J; Guo Q; Barnabo Nampoukime KP; Yang P; Ma K J Cell Mol Med; 2018 Dec; 22(12):5862-5876. PubMed ID: 30246921 [TBL] [Abstract][Full Text] [Related]
11. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway. Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952 [TBL] [Abstract][Full Text] [Related]
12. LncSNHG3 promotes hepatocellular carcinoma epithelial mesenchymal transition progression through the miR-152-3p/JAK1 pathway. Li H; Wu Y; Wang R; Guo J; Yu Q; Zhang L; Zhao H; Yang H Genes Genomics; 2022 Jan; 44(1):133-144. PubMed ID: 34778942 [TBL] [Abstract][Full Text] [Related]
13. MicroRNA-639 is Down-Regulated in Hepatocellular Carcinoma Tumor Tissue and Inhibits Proliferation and Migration of Human Hepatocellular Carcinoma Cells Through the KAT7/Wnt/β-Catenin Pathway. Bai Z; Xia X; Lu J Med Sci Monit; 2020 Jan; 26():e919241. PubMed ID: 31955177 [TBL] [Abstract][Full Text] [Related]
14. LncRNA ANCR promotes hepatocellular carcinoma metastasis through upregulating HNRNPA1 expression. Wen Z; Lian L; Ding H; Hu Y; Xiao Z; Xiong K; Yang Q RNA Biol; 2020 Mar; 17(3):381-394. PubMed ID: 31868085 [TBL] [Abstract][Full Text] [Related]
15. Hsa_circ_0003998 promotes epithelial to mesenchymal transition of hepatocellular carcinoma by sponging miR-143-3p and PCBP1. Song LN; Qiao GL; Yu J; Yang CM; Chen Y; Deng ZF; Song LH; Ma LJ; Yan HL J Exp Clin Cancer Res; 2020 Jun; 39(1):114. PubMed ID: 32552766 [TBL] [Abstract][Full Text] [Related]
16. miR-186 Represses Proliferation, Migration, Invasion, and EMT of Hepatocellular Carcinoma via Directly Targeting CDK6. Lu J; Zhao Z; Ma Y Oncol Res; 2020 Dec; 28(5):509-518. PubMed ID: 32698940 [TBL] [Abstract][Full Text] [Related]
17. CASC15 promotes epithelial to mesenchymal transition and facilitates malignancy of hepatocellular carcinoma cells by increasing TWIST1 gene expression via miR-33a-5p sponging. Li Y; Chen G; Yan Y; Fan Q Eur J Pharmacol; 2019 Oct; 860():172589. PubMed ID: 31401158 [TBL] [Abstract][Full Text] [Related]
18. Role of microRNA-141-3p in the progression and metastasis of hepatocellular carcinoma cell. Hou X; Yang L; Jiang X; Liu Z; Li X; Xie S; Li G; Liu J Int J Biol Macromol; 2019 May; 128():331-339. PubMed ID: 30695725 [TBL] [Abstract][Full Text] [Related]
19. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis. Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150 [No Abstract] [Full Text] [Related]
20. MicroRNA-451: epithelial-mesenchymal transition inhibitor and prognostic biomarker of hepatocelluar carcinoma. Huang JY; Zhang K; Chen DQ; Chen J; Feng B; Song H; Chen Y; Zhu Z; Lu L; De W; Wang R; Chen LB Oncotarget; 2015 Jul; 6(21):18613-30. PubMed ID: 26164082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]